Teruhisa Higuchi

  • Citations Per Year
Learn More
We administered zinc supplementation therapy over three years to patients with chronic hepatitis C and reported and that the aspartate aminotransferase (AST) and alanine aminotaransferase (ALT) levels decreased, and platelet counts increased, significantly in the group with increased serum zinc concentrations. We are continuing this treatment to clarify the(More)
AIM To evaluate the histopathological findings of type C liver disease to determine risk factors for development of hepatocellular carcinoma (HCC). METHODS We studied 232 patients, who underwent liver biopsy for type C chronic liver disease between 1992 and 2009, with sustained virological response (SVR) after interferon therapy. The patients were divided(More)
BACKGROUND AND AIMS In chronic hepatitis C patients with genotype 1b and a high viral load, the sustained virological response (SVR) rate remained as low as 2-3% with conventional interferon (IFN) monotherapy, but improved to more than 20% with IFN alpha-2b plus ribavirin combination therapy. This study examined the therapeutic effects and predictors of(More)
We reported CT and MRI findings of heterotopic gray matter in two patients with intractable convulsive seizures. CT demonstrated space-occupying but non-expansive lesions isodense with the cortical gray matter adjacent to the body of the lateral ventricle. These lesions were not enhanced with contrast infusion. MRI was performed in one case in which the(More)
  • 1